| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
29,289 |
27,187 |
$5.03M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
30,152 |
27,412 |
$4.97M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
8,794 |
8,196 |
$1.52M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,880 |
4,698 |
$1.29M |
| 97602 |
|
2,940 |
1,177 |
$1.22M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,322 |
2,875 |
$1.14M |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,722 |
3,630 |
$1.00M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,871 |
847 |
$964K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,978 |
2,927 |
$810K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,752 |
4,606 |
$750K |
| 80053 |
Comprehensive metabolic panel |
32,724 |
29,378 |
$604K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
592 |
589 |
$535K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,472 |
1,449 |
$424K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,859 |
1,805 |
$399K |
| 36415 |
Collection of venous blood by venipuncture |
58,122 |
34,420 |
$367K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,018 |
1,726 |
$289K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
886 |
882 |
$276K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
13,225 |
12,529 |
$262K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
13,424 |
11,343 |
$255K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
38,957 |
24,601 |
$241K |
| G0378 |
Hospital observation service, per hour |
1,664 |
861 |
$238K |
| 12001 |
|
525 |
523 |
$237K |
| 86850 |
|
5,957 |
5,639 |
$217K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,108 |
1,047 |
$188K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
231 |
227 |
$182K |
| 86901 |
|
6,137 |
5,750 |
$163K |
| 59025 |
Fetal non-stress test |
1,661 |
1,343 |
$153K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
287 |
285 |
$150K |
| 86900 |
|
6,130 |
5,751 |
$136K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,466 |
1,440 |
$118K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
740 |
699 |
$116K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
3,128 |
3,011 |
$95K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,386 |
1,232 |
$86K |
| 83880 |
|
2,776 |
2,612 |
$83K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,092 |
1,960 |
$82K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,754 |
1,685 |
$67K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,246 |
4,687 |
$65K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,140 |
732 |
$64K |
| 12011 |
|
129 |
126 |
$61K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,565 |
1,540 |
$56K |
| 80061 |
Lipid panel |
6,277 |
6,195 |
$51K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
407 |
385 |
$47K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
454 |
174 |
$46K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,271 |
1,213 |
$46K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,408 |
1,382 |
$45K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,288 |
5,146 |
$45K |
| 29515 |
|
182 |
181 |
$44K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,828 |
1,809 |
$43K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,938 |
4,860 |
$38K |
| 88342 |
|
412 |
404 |
$30K |
| 76801 |
|
242 |
225 |
$30K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,084 |
365 |
$29K |
| 90715 |
|
1,095 |
1,092 |
$29K |
| 71046 |
Radiologic examination, chest; 2 views |
3,216 |
3,167 |
$28K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
110 |
110 |
$27K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
474 |
467 |
$26K |
| 12002 |
|
56 |
56 |
$26K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,401 |
1,376 |
$25K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
90 |
90 |
$25K |
| 97161 |
|
233 |
224 |
$24K |
| 93970 |
|
39 |
39 |
$24K |
| 93971 |
|
187 |
184 |
$22K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
314 |
303 |
$21K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
111 |
99 |
$18K |
| 86703 |
|
1,407 |
1,394 |
$18K |
| 84439 |
|
2,538 |
2,514 |
$17K |
| 29125 |
|
76 |
74 |
$17K |
| 82607 |
|
1,505 |
1,492 |
$16K |
| 86618 |
|
1,180 |
1,041 |
$15K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
291 |
259 |
$15K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
10,312 |
9,475 |
$15K |
| 85027 |
|
3,952 |
3,572 |
$14K |
| 82248 |
|
10,957 |
10,142 |
$13K |
| 80076 |
|
1,119 |
1,088 |
$12K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
982 |
856 |
$12K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14,140 |
13,155 |
$12K |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
4,894 |
2,598 |
$11K |
| 88304 |
|
175 |
175 |
$10K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
12 |
12 |
$10K |
| 82728 |
|
848 |
835 |
$9K |
| 85610 |
|
4,698 |
4,237 |
$9K |
| 86803 |
|
1,169 |
1,160 |
$9K |
| 81003 |
|
13,312 |
12,340 |
$9K |
| 82746 |
|
823 |
819 |
$9K |
| 97116 |
|
235 |
122 |
$8K |
| 76000 |
|
31 |
25 |
$8K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
42 |
42 |
$8K |
| J3490 |
Unclassified drugs |
219 |
168 |
$8K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
12 |
12 |
$7K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
510 |
483 |
$6K |
| 71045 |
Radiologic examination, chest; single view |
6,588 |
6,299 |
$6K |
| 83540 |
|
1,291 |
1,278 |
$6K |
| 87040 |
|
1,434 |
1,340 |
$6K |
| 83735 |
|
4,282 |
3,812 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
173 |
58 |
$5K |
| 99157 |
|
3,658 |
3,563 |
$5K |
| 97162 |
|
40 |
40 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
9,341 |
8,718 |
$5K |
| 70486 |
|
45 |
42 |
$5K |
| 83550 |
|
898 |
888 |
$5K |
| 81025 |
|
1,531 |
1,499 |
$5K |
| 82043 |
|
926 |
920 |
$4K |
| 85730 |
|
2,947 |
2,818 |
$4K |
| 84153 |
|
247 |
244 |
$4K |
| 86140 |
|
1,717 |
1,542 |
$4K |
| 76830 |
Ultrasound, transvaginal |
53 |
52 |
$4K |
| 82803 |
|
146 |
140 |
$3K |
| 82550 |
|
3,090 |
2,925 |
$3K |
| 87631 |
|
48 |
48 |
$3K |
| 86592 |
|
1,167 |
1,153 |
$3K |
| 72131 |
|
14 |
14 |
$3K |
| 87641 |
|
133 |
131 |
$3K |
| 84481 |
|
274 |
272 |
$3K |
| 87088 |
|
3,323 |
3,231 |
$3K |
| 87640 |
|
132 |
130 |
$3K |
| 84703 |
|
4,975 |
4,586 |
$2K |
| 84550 |
|
697 |
673 |
$2K |
| 84484 |
|
5,951 |
5,274 |
$2K |
| 84702 |
|
3,222 |
3,001 |
$2K |
| 87070 |
|
985 |
925 |
$2K |
| 80349 |
|
596 |
556 |
$2K |
| 86617 |
|
146 |
143 |
$2K |
| 80358 |
|
600 |
559 |
$2K |
| 80353 |
|
484 |
452 |
$2K |
| 76377 |
|
1,234 |
1,199 |
$2K |
| 84480 |
|
406 |
403 |
$2K |
| 83690 |
|
6,637 |
6,204 |
$2K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
12 |
12 |
$2K |
| 84436 |
|
593 |
588 |
$2K |
| 80323 |
|
295 |
276 |
$1K |
| 80361 |
|
295 |
276 |
$1K |
| 80348 |
|
295 |
276 |
$1K |
| 80346 |
|
295 |
276 |
$1K |
| 80356 |
|
294 |
275 |
$1K |
| 80324 |
|
294 |
275 |
$1K |
| 80365 |
|
295 |
276 |
$1K |
| 80362 |
|
295 |
276 |
$1K |
| 80367 |
|
294 |
275 |
$1K |
| 80359 |
|
296 |
277 |
$1K |
| 80345 |
|
295 |
276 |
$1K |
| 0012A |
|
70 |
70 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
37 |
24 |
$1K |
| 88341 |
|
13 |
12 |
$1K |
| 97010 |
|
113 |
44 |
$1K |
| 82947 |
|
1,692 |
1,284 |
$1K |
| 86038 |
|
163 |
162 |
$1K |
| 87186 |
|
484 |
470 |
$1K |
| 86710 |
|
38 |
18 |
$1K |
| 85651 |
|
426 |
378 |
$1K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,226 |
1,108 |
$1K |
| 99156 |
|
3,878 |
3,768 |
$985.11 |
| 84100 |
|
1,283 |
1,152 |
$924.96 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,327 |
1,202 |
$868.20 |
| 87077 |
|
804 |
784 |
$852.19 |
| 85652 |
|
1,068 |
948 |
$811.85 |
| 0011A |
|
68 |
68 |
$807.62 |
| 87252 |
|
238 |
224 |
$802.19 |
| 76857 |
|
44 |
44 |
$757.57 |
| 96376 |
|
968 |
932 |
$721.21 |
| 87522 |
Neg quan hep c or qual rna |
15 |
15 |
$665.79 |
| 86480 |
|
13 |
13 |
$642.10 |
| J8501 |
Aprepitant, oral, 5 mg |
13 |
13 |
$610.64 |
| 83605 |
|
1,176 |
1,086 |
$560.27 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
78 |
73 |
$552.04 |
| C1769 |
Guide wire |
82 |
71 |
$523.35 |
| 85378 |
|
939 |
923 |
$506.65 |
| 87184 |
|
818 |
806 |
$446.72 |
| 82150 |
|
1,836 |
1,788 |
$434.16 |
| 82553 |
|
496 |
464 |
$407.27 |
| 82805 |
|
14 |
14 |
$401.27 |
| 87081 |
|
1,661 |
1,643 |
$389.32 |
| 73030 |
|
90 |
87 |
$361.93 |
| 84403 |
|
15 |
13 |
$355.67 |
| 73630 |
|
321 |
316 |
$336.40 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
251 |
232 |
$316.43 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,735 |
1,713 |
$291.65 |
| 74018 |
|
62 |
58 |
$281.38 |
| 81015 |
|
7,841 |
7,509 |
$263.50 |
| 73610 |
|
377 |
370 |
$263.20 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,324 |
829 |
$251.69 |
| 82384 |
|
240 |
226 |
$241.57 |
| 0002A |
|
13 |
13 |
$237.88 |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,705 |
1,191 |
$232.63 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,713 |
5,181 |
$230.03 |
| C1889 |
Implantable/insertable device, not otherwise classified |
25 |
24 |
$196.63 |
| 86431 |
|
40 |
40 |
$193.65 |
| 81001 |
|
1,308 |
1,249 |
$186.54 |
| 73110 |
|
79 |
79 |
$175.57 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
749 |
648 |
$170.46 |
| 86706 |
|
29 |
29 |
$164.75 |
| 80320 |
|
719 |
670 |
$152.97 |
| 73560 |
|
191 |
188 |
$145.14 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
471 |
450 |
$113.12 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,134 |
1,067 |
$107.31 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,929 |
1,576 |
$101.85 |
| 80050 |
General health panel |
211 |
209 |
$90.00 |
| J2704 |
Injection, propofol, 10 mg |
2,555 |
2,399 |
$89.08 |
| 87205 |
|
107 |
104 |
$76.55 |
| 73562 |
|
44 |
44 |
$69.49 |
| 85007 |
|
1,218 |
1,126 |
$68.30 |
| 82247 |
|
14 |
12 |
$64.08 |
| 87340 |
|
15 |
15 |
$61.65 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,837 |
1,773 |
$58.95 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,387 |
4,880 |
$52.38 |
| 86430 |
|
12 |
12 |
$48.44 |
| 73130 |
|
195 |
192 |
$47.33 |
| 82570 |
|
12 |
12 |
$46.63 |
| 83615 |
|
29 |
28 |
$44.23 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
130 |
129 |
$41.60 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,611 |
5,137 |
$41.20 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,844 |
1,768 |
$40.28 |
| 80364 |
|
236 |
220 |
$37.83 |
| 84156 |
|
12 |
12 |
$32.14 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,518 |
2,374 |
$32.01 |
| J3535 |
Drug administered through a metered dose inhaler |
561 |
532 |
$30.43 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
32 |
28 |
$27.80 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
885 |
811 |
$27.66 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
423 |
207 |
$21.90 |
| 84145 |
|
13 |
13 |
$21.78 |
| 80329 |
|
264 |
252 |
$16.04 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,553 |
1,515 |
$13.93 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
247 |
204 |
$12.52 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,940 |
1,831 |
$9.50 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
151 |
135 |
$8.49 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
2,077 |
1,947 |
$7.90 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
230 |
225 |
$6.81 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
59 |
58 |
$3.40 |
| 86308 |
|
33 |
33 |
$2.70 |
| J2060 |
Injection, lorazepam, 2 mg |
113 |
103 |
$1.44 |
| J1644 |
Injection, heparin sodium, per 1000 units |
109 |
68 |
$1.22 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
176 |
169 |
$0.81 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
716 |
664 |
$0.02 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
550 |
483 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
45 |
42 |
$0.00 |
| 87807 |
|
29 |
29 |
$0.00 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
15 |
15 |
$0.00 |
| 94760 |
|
32 |
30 |
$0.00 |
| 99080 |
|
2,835 |
668 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
52 |
52 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
68 |
65 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
13 |
13 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
42 |
39 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
16 |
12 |
$0.00 |
| 86771 |
|
12 |
12 |
$0.00 |
| 88313 |
|
13 |
12 |
$0.00 |